Inventor · disambiguated record
Dante J. Marciani
Also filed as: MARCIANI DANTE · MARCIANI DANTE J
17 granted patents·1 pending application·2,703 citations·filing 1986–2014
96Inventor score
Files withCAMBRIDGE BIOTECH CORP6GALENICA PHARMACEUTICALS INC6CAMBRIDGE BIOSCIENCE CORP4ADJUVANTYS INC1QANTU THERAPEUTICS INC1
Top patents by PatentIndex Score
18 records- 0198US5057540ASaponin adjuvantCAMBRIDGE BIOTECH CORP·Filed 1990·Granted Oct 15, 1991·1.4k cites·16 claims
- 0295US6080725AImmunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereofGALENICA PHARMACEUTICALS INC·Filed 1999·Granted Jun 27, 2000·281 cites·37 claims
- 0394US6262029B1Chemically modified saponins and the use thereof as adjuvantsGALENICA PHARMACEUTICALS INC·Filed 1999·Granted Jul 17, 2001·98 cites·38 claims
- 0490US6573245B1Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereofGALENICA PHARMACEUTICALS INC·Filed 1999·Granted Jun 3, 2003·137 cites·31 claims
- 0589US7196073B2Imine-forming polysaccharide adjuvants and immunostimulantsADJUVANTYS INC·Filed 2004·Granted Mar 27, 2007·36 cites·19 claims
- 0689US5977081ATriterpene saponin analogs having adjuvant and immunostimulatory activityGALENICA PHARMACEUTICALS INC·Filed 1998·Granted Nov 2, 1999·113 cites·50 claims
- 0789US5583112ASaponin-antigen conjugates and the use thereofCAMBRIDGE BIOTECH CORP·Filed 1992·Granted Dec 10, 1996·175 cites·50 claims
- 0887US4753873APeptides for the diagnosis of HTLV-III antibodies, their preparation and useCAMBRIDGE BIOSCIENCE CORP·Filed 1986·Granted Jun 28, 1988·66 cites·17 claims
- 0985US5443829AModified saponins isolated from Quillaja saponariaCAMBRIDGE BIOTECH CORP·Filed 1993·Granted Aug 22, 1995·81 cites·22 claims
- 1085US5273965AMethods for enhancing drug delivery with modified saponinsCAMBRIDGE BIOTECH CORP·Filed 1992·Granted Dec 28, 1993·82 cites·43 claims
- 1184US5231003AMonoclonal antibodies specific for toxin b of clostridium difficileCAMBRIDGE BIOSCIENCE CORP·Filed 1990·Granted Jul 27, 1993·63 cites·9 claims
- 1284US4734362AProcess for purifying recombinant proteins, and products thereofCAMBRIDGE BIOSCIENCE CORP·Filed 1986·Granted Mar 29, 1988·60 cites·37 claims
- 1381US5650398ADrug delivery enhancement via modified saponinsCAMBRIDGE BIOTECH CORP·Filed 1995·Granted Jul 22, 1997·69 cites·49 claims
- 1480US6960344B2Use of imine-forming polysaccharides as adjuvants and immunostimulantsGALENICA PHARMACEUTICALS INC·Filed 2002·Granted Nov 1, 2005·8 cites·41 claims
- 1571US5352449AVaccine comprising recombinant feline leukemia antigen and saponin adjuvantCAMBRIDGE BIOTECH CORP·Filed 1992·Granted Oct 4, 1994·40 cites·9 claims
- 1662US4921787ADetection of antibodies to human immunodeficiency virus by agglutination of antigen coated latexCAMBRIDGE BIOSCIENCE CORP·Filed 1987·Granted May 1, 1990·23 cites·9 claims
- 1751US10195257B2Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune responseQANTU THERAPEUTICS INC·Filed 2014·Granted Feb 5, 2019·0 cites·7 claims
- 1846US2004242502A1Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccinesGALENICA PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →